The IBN SINA Pharmaceutical Industry PLC (DSE: IBNSINA)

Market Cap	9.01B
Revenue (ttm)	11.23B
Net Income (ttm)	592.31M
Shares Out	31.24M
EPS (ttm)	18.96
PE Ratio	15.21
Forward PE	12.48
Dividend	6.30 (2.19%)
Ex-Dividend Date	Oct 28, 2024

Volume	57,775
Average Volume	33,779
Open	293.00
Previous Close	291.60
Day's Range	291.00 - 295.00
52-Week Range	223.50 - 384.80
Beta	0.23
RSI	48.72
Earnings Date	Jan 27, 2025

About DSE: IBNSINA

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflamma...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 4,200
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: IBNSINA

Financial Performance

In 2024, IBNSINA's revenue was 11.37 billion, an increase of 24.61% compared to the previous year's 9.13 billion. Earnings were 670.52 million, an increase of 10.75%.